Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 6;107(3):388-97.
doi: 10.1161/CIRCRESAHA.110.218651. Epub 2010 Jun 17.

P-selectin glycoprotein ligand-1 regulates adhesive properties of the endothelium and leukocyte trafficking into adipose tissue

Hana M Russo  1 , Kevin J Wickenheiser, Wei Luo, Miina K Ohman, Luigi Franchi, Andrew P Wright, Peter F Bodary, Gabriel Núñez, Daniel T Eitzman
Affiliations

P-selectin glycoprotein ligand-1 regulates adhesive properties of the endothelium and leukocyte trafficking into adipose tissue

Hana M Russo et al. Circ Res. .

Erratum in

  • Circ Res. 2010 Sep 17;107(6):e13. Gabriel, Núñez [corrected to Núñez, Gabriel]

Abstract

Rationale: Adhesive interactions between endothelial cells and leukocytes affect leukocyte trafficking in adipose tissue. The role of P-selectin glycoprotein ligand-1 (Psgl-1) in this process is unclear.

Objective: The goal of this study was to determine the effect of Psgl-1 deficiency on adhesive properties of the endothelium and on leukocyte recruitment into obese adipose depots.

Methods and results: A genetic model of obesity was generated to study the effects of Psgl-1 deficiency on leukocyte trafficking. Leukocyte-endothelial interactions were increased in obese leptin receptor mutant mice (Lepr(db/db),Psgl-1(+/+)) but not obese Psgl-1-deficient mice (Lepr(db/db),Psgl-1(-/-)), when compared with lean mice (Lepr(+/+),Psgl-1(+/+)). This effect of Psgl-1 deficiency was due to indirect effects of Psgl-1, because Psgl-1(+/+) adoptively transferred leukocytes did not exhibit enhanced rolling in Lepr (db/db),Psgl-1(-/-) mice. Additionally, circulating levels of P-selectin, E-selectin, monocyte chemoattractant protein-1, and macrophage content of visceral adipose tissue were reduced in Lepr(db/db),Psgl-1(-/-) compared with Lepr(db/db),Psgl-1(+/+) mice. Reduced leukocyte-endothelial interactions and macrophage content of visceral adipose tissue due to Psgl-1 deficiency was also observed in a diet-induced obese mouse model. Psgl-1(-/-) mice were resistant to the endothelial effects of exogenous IL-1beta, suggesting that defective cytokine signaling contributes to the effect of Psgl-1 deficiency on leukocyte-endothelial interactions. Mice deficient in the IL-1 receptor also had reduced levels of circulating P-selectin, similar to those observed in Psgl-1(-/-) mice.

Conclusions: Deficiency of Psgl-1 is associated with reduced IL-1 receptor-mediated adhesive properties of the endothelium and is protective against visceral fat inflammation in obese mice.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Circulating sP-sel, sE-sel, and MCP-1 at 5, 10, and 15 weeks of age
Leprdb/db,Psgl-1+/+ (black bars) and Leprdb/db,Psgl-1−/− mice (white bars). Five week time point for Leprdb/db,Psgl-1+/+ mice (n=5-7). All other time points for Leprdb/db,Psgl-1+/+ and Leprdb/db, Psgl-1−/− mice (n=7-13). A) sP-sel levels. B) sE-sel levels. C) MCP-1 levels. Psgl-1+/+ (black bars) (n=5) and Psgl-1−/− mice (white bars) (n=3-5) on high-fat, high-sucrose diet. D) sP-sel levels. E) sE-sel levels. F) MCP-1 levels. *p<0.05, **p<0.01, ***p<0.001.
Figure 1
Figure 1. Circulating sP-sel, sE-sel, and MCP-1 at 5, 10, and 15 weeks of age
Leprdb/db,Psgl-1+/+ (black bars) and Leprdb/db,Psgl-1−/− mice (white bars). Five week time point for Leprdb/db,Psgl-1+/+ mice (n=5-7). All other time points for Leprdb/db,Psgl-1+/+ and Leprdb/db, Psgl-1−/− mice (n=7-13). A) sP-sel levels. B) sE-sel levels. C) MCP-1 levels. Psgl-1+/+ (black bars) (n=5) and Psgl-1−/− mice (white bars) (n=3-5) on high-fat, high-sucrose diet. D) sP-sel levels. E) sE-sel levels. F) MCP-1 levels. *p<0.05, **p<0.01, ***p<0.001.
Figure 1
Figure 1. Circulating sP-sel, sE-sel, and MCP-1 at 5, 10, and 15 weeks of age
Leprdb/db,Psgl-1+/+ (black bars) and Leprdb/db,Psgl-1−/− mice (white bars). Five week time point for Leprdb/db,Psgl-1+/+ mice (n=5-7). All other time points for Leprdb/db,Psgl-1+/+ and Leprdb/db, Psgl-1−/− mice (n=7-13). A) sP-sel levels. B) sE-sel levels. C) MCP-1 levels. Psgl-1+/+ (black bars) (n=5) and Psgl-1−/− mice (white bars) (n=3-5) on high-fat, high-sucrose diet. D) sP-sel levels. E) sE-sel levels. F) MCP-1 levels. *p<0.05, **p<0.01, ***p<0.001.
Figure 1
Figure 1. Circulating sP-sel, sE-sel, and MCP-1 at 5, 10, and 15 weeks of age
Leprdb/db,Psgl-1+/+ (black bars) and Leprdb/db,Psgl-1−/− mice (white bars). Five week time point for Leprdb/db,Psgl-1+/+ mice (n=5-7). All other time points for Leprdb/db,Psgl-1+/+ and Leprdb/db, Psgl-1−/− mice (n=7-13). A) sP-sel levels. B) sE-sel levels. C) MCP-1 levels. Psgl-1+/+ (black bars) (n=5) and Psgl-1−/− mice (white bars) (n=3-5) on high-fat, high-sucrose diet. D) sP-sel levels. E) sE-sel levels. F) MCP-1 levels. *p<0.05, **p<0.01, ***p<0.001.
Figure 1
Figure 1. Circulating sP-sel, sE-sel, and MCP-1 at 5, 10, and 15 weeks of age
Leprdb/db,Psgl-1+/+ (black bars) and Leprdb/db,Psgl-1−/− mice (white bars). Five week time point for Leprdb/db,Psgl-1+/+ mice (n=5-7). All other time points for Leprdb/db,Psgl-1+/+ and Leprdb/db, Psgl-1−/− mice (n=7-13). A) sP-sel levels. B) sE-sel levels. C) MCP-1 levels. Psgl-1+/+ (black bars) (n=5) and Psgl-1−/− mice (white bars) (n=3-5) on high-fat, high-sucrose diet. D) sP-sel levels. E) sE-sel levels. F) MCP-1 levels. *p<0.05, **p<0.01, ***p<0.001.
Figure 1
Figure 1. Circulating sP-sel, sE-sel, and MCP-1 at 5, 10, and 15 weeks of age
Leprdb/db,Psgl-1+/+ (black bars) and Leprdb/db,Psgl-1−/− mice (white bars). Five week time point for Leprdb/db,Psgl-1+/+ mice (n=5-7). All other time points for Leprdb/db,Psgl-1+/+ and Leprdb/db, Psgl-1−/− mice (n=7-13). A) sP-sel levels. B) sE-sel levels. C) MCP-1 levels. Psgl-1+/+ (black bars) (n=5) and Psgl-1−/− mice (white bars) (n=3-5) on high-fat, high-sucrose diet. D) sP-sel levels. E) sE-sel levels. F) MCP-1 levels. *p<0.05, **p<0.01, ***p<0.001.
Figure 2
Figure 2. Macrophage content of perigonadal, pericardial, and subcutaneous adipose tissue
A) Macrophage content of perigonadal (n=7-10), pericardial (n=7-8), and subcutaneous (n=5-8) adipose tissue in Leprdb/db,Psgl-1+/+ (black bars) and Leprdb/db,Psgl-1−/− mice (white bars) at 15 weeks of age. B) Macrophage content of perigonadal and subcutaneous adipose tissue in Psgl-1+/+ (black bars) (n=4) and Psgl-1−/− mice (white bars) (n=5) after 10 weeks of high-fat, high-sucrose diet at 15 weeks of age. Representative cross sections of perigonadal adipose tissue from C) Psgl-1−/− and D) Psgl-1+/+ mice, and subcutaneous adipose tissue from E) Psgl-1−/− and F) Psgl-1+/+ mice 10 weeks after high-fat, high-sucrose diet. Staining with Mac3 antibody, magnification 40X, scale bar 200 μm, arrows showing stained cells. *p<0.05, **p<0.01, ***p<0.001.
Figure 2
Figure 2. Macrophage content of perigonadal, pericardial, and subcutaneous adipose tissue
A) Macrophage content of perigonadal (n=7-10), pericardial (n=7-8), and subcutaneous (n=5-8) adipose tissue in Leprdb/db,Psgl-1+/+ (black bars) and Leprdb/db,Psgl-1−/− mice (white bars) at 15 weeks of age. B) Macrophage content of perigonadal and subcutaneous adipose tissue in Psgl-1+/+ (black bars) (n=4) and Psgl-1−/− mice (white bars) (n=5) after 10 weeks of high-fat, high-sucrose diet at 15 weeks of age. Representative cross sections of perigonadal adipose tissue from C) Psgl-1−/− and D) Psgl-1+/+ mice, and subcutaneous adipose tissue from E) Psgl-1−/− and F) Psgl-1+/+ mice 10 weeks after high-fat, high-sucrose diet. Staining with Mac3 antibody, magnification 40X, scale bar 200 μm, arrows showing stained cells. *p<0.05, **p<0.01, ***p<0.001.
Figure 2
Figure 2. Macrophage content of perigonadal, pericardial, and subcutaneous adipose tissue
A) Macrophage content of perigonadal (n=7-10), pericardial (n=7-8), and subcutaneous (n=5-8) adipose tissue in Leprdb/db,Psgl-1+/+ (black bars) and Leprdb/db,Psgl-1−/− mice (white bars) at 15 weeks of age. B) Macrophage content of perigonadal and subcutaneous adipose tissue in Psgl-1+/+ (black bars) (n=4) and Psgl-1−/− mice (white bars) (n=5) after 10 weeks of high-fat, high-sucrose diet at 15 weeks of age. Representative cross sections of perigonadal adipose tissue from C) Psgl-1−/− and D) Psgl-1+/+ mice, and subcutaneous adipose tissue from E) Psgl-1−/− and F) Psgl-1+/+ mice 10 weeks after high-fat, high-sucrose diet. Staining with Mac3 antibody, magnification 40X, scale bar 200 μm, arrows showing stained cells. *p<0.05, **p<0.01, ***p<0.001.
Figure 3
Figure 3. Circulating sP-sel, sE-sel, MCP-1, and sICAM-1 and expression of P-sel, E-sel, and MCP-1 in lung and perigonadal fat 5 hours following IL-1β injection
Psgl-1+/+ (n=4), Psgl-1−/− (n=3), and IL-lR−/− mice (n=3). A) sP-sel levels, B) sE-sel levels, C) MCP-1 levels, and D) sICAM-1 levels in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− mice before IL-1β challenge (black bar) and after IL-1β challenge (white bar). Expression of P-sel, E-sel, and MCP-1 in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− in E) lung and in F) perigonadal fat following PBS injection (black bar) and following IL-1β challenge (white bar). * p<0.05, **p<0.01, ***p<0.001.
Figure 3
Figure 3. Circulating sP-sel, sE-sel, MCP-1, and sICAM-1 and expression of P-sel, E-sel, and MCP-1 in lung and perigonadal fat 5 hours following IL-1β injection
Psgl-1+/+ (n=4), Psgl-1−/− (n=3), and IL-lR−/− mice (n=3). A) sP-sel levels, B) sE-sel levels, C) MCP-1 levels, and D) sICAM-1 levels in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− mice before IL-1β challenge (black bar) and after IL-1β challenge (white bar). Expression of P-sel, E-sel, and MCP-1 in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− in E) lung and in F) perigonadal fat following PBS injection (black bar) and following IL-1β challenge (white bar). * p<0.05, **p<0.01, ***p<0.001.
Figure 3
Figure 3. Circulating sP-sel, sE-sel, MCP-1, and sICAM-1 and expression of P-sel, E-sel, and MCP-1 in lung and perigonadal fat 5 hours following IL-1β injection
Psgl-1+/+ (n=4), Psgl-1−/− (n=3), and IL-lR−/− mice (n=3). A) sP-sel levels, B) sE-sel levels, C) MCP-1 levels, and D) sICAM-1 levels in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− mice before IL-1β challenge (black bar) and after IL-1β challenge (white bar). Expression of P-sel, E-sel, and MCP-1 in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− in E) lung and in F) perigonadal fat following PBS injection (black bar) and following IL-1β challenge (white bar). * p<0.05, **p<0.01, ***p<0.001.
Figure 3
Figure 3. Circulating sP-sel, sE-sel, MCP-1, and sICAM-1 and expression of P-sel, E-sel, and MCP-1 in lung and perigonadal fat 5 hours following IL-1β injection
Psgl-1+/+ (n=4), Psgl-1−/− (n=3), and IL-lR−/− mice (n=3). A) sP-sel levels, B) sE-sel levels, C) MCP-1 levels, and D) sICAM-1 levels in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− mice before IL-1β challenge (black bar) and after IL-1β challenge (white bar). Expression of P-sel, E-sel, and MCP-1 in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− in E) lung and in F) perigonadal fat following PBS injection (black bar) and following IL-1β challenge (white bar). * p<0.05, **p<0.01, ***p<0.001.
Figure 3
Figure 3. Circulating sP-sel, sE-sel, MCP-1, and sICAM-1 and expression of P-sel, E-sel, and MCP-1 in lung and perigonadal fat 5 hours following IL-1β injection
Psgl-1+/+ (n=4), Psgl-1−/− (n=3), and IL-lR−/− mice (n=3). A) sP-sel levels, B) sE-sel levels, C) MCP-1 levels, and D) sICAM-1 levels in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− mice before IL-1β challenge (black bar) and after IL-1β challenge (white bar). Expression of P-sel, E-sel, and MCP-1 in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− in E) lung and in F) perigonadal fat following PBS injection (black bar) and following IL-1β challenge (white bar). * p<0.05, **p<0.01, ***p<0.001.
Figure 3
Figure 3. Circulating sP-sel, sE-sel, MCP-1, and sICAM-1 and expression of P-sel, E-sel, and MCP-1 in lung and perigonadal fat 5 hours following IL-1β injection
Psgl-1+/+ (n=4), Psgl-1−/− (n=3), and IL-lR−/− mice (n=3). A) sP-sel levels, B) sE-sel levels, C) MCP-1 levels, and D) sICAM-1 levels in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− mice before IL-1β challenge (black bar) and after IL-1β challenge (white bar). Expression of P-sel, E-sel, and MCP-1 in Psgl-1+/+, Psgl-1−/−, and IL-lR−/− in E) lung and in F) perigonadal fat following PBS injection (black bar) and following IL-1β challenge (white bar). * p<0.05, **p<0.01, ***p<0.001.
Figure 4
Figure 4. Circulating levels of sP-sel in mice at baseline
Wild-type (Wt) (black bar) (n=11), Psgl-1−/− (white bar) (n=10), and IL-1R−/− mice (diagonal striped bar) (n=15) ***p<0.001.
Figure 5
Figure 5. Relevant source of IL-1R and Psgl-1 for endothelial selectin regulation
A) sP-sel levels in IL-1R+/+ mice that had received IL-1R−/− bone marrow (n=4) and IL-1R−/− mice that had received IL-1R+/+ bone marrow (n=6) before IL-1β injection (black bars) and 5 hours following IL-1β injection (white bars). B) sP-sel levels in Psgl-1−/− mice that had received Psgl-1+/+ marrow (n=3) and Psgl-1+/+ mice that had received Psgl-1−/− marrow (n=6) before IL-1β injection (black bars) and 5 hours following IL-1β injection (white bars). *p<0.05. ***p<0.001.
Figure 5
Figure 5. Relevant source of IL-1R and Psgl-1 for endothelial selectin regulation
A) sP-sel levels in IL-1R+/+ mice that had received IL-1R−/− bone marrow (n=4) and IL-1R−/− mice that had received IL-1R+/+ bone marrow (n=6) before IL-1β injection (black bars) and 5 hours following IL-1β injection (white bars). B) sP-sel levels in Psgl-1−/− mice that had received Psgl-1+/+ marrow (n=3) and Psgl-1+/+ mice that had received Psgl-1−/− marrow (n=6) before IL-1β injection (black bars) and 5 hours following IL-1β injection (white bars). *p<0.05. ***p<0.001.
Figure 6
Figure 6. Activation of NFκB in Psgl-1+/+ and Psgl-1−/− mice following IL-1β challenge
Extracts from total lung homogenates from Psgl-1+/+ (WT) and Psgl-1−/− (KO) mice were probed with antibodies that detect total and phosphorylated IκBα or p38.
Figure 7
Figure 7
Hematopoietic Psgl-1 regulates endothelial response to IL-1β
See this image and copyright information in PMC

References

    1. Jiao P, Chen Q, Shah S, Du J, Tao B, Tzameli I, Yan W, Xu H. Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes: Involvement of Nuclear Factor-{kappa}B and c-Jun NH2-Terminal Kinase Pathways. Diabetes. 2009;58:104–115. - PMC - PubMed
    1. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW., Jr Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–1808. - PMC - PubMed
    1. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112:1785–1788. - PMC - PubMed
    1. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–1830. - PMC - PubMed
    1. Bullard DC. Adhesion molecules in inflammatory diseases: insights from knockout mice. Immunol Res. 2002;26:27–33. - PubMed

Publication types

MeSH terms